Vaccines for fertility regulation of wild and domestic species

Citation
Mp. Bradley et al., Vaccines for fertility regulation of wild and domestic species, J BIOTECH, 73(2-3), 1999, pp. 91-101
Citations number
48
Categorie Soggetti
Biotecnology & Applied Microbiology",Microbiology
Journal title
JOURNAL OF BIOTECHNOLOGY
ISSN journal
01681656 → ACNP
Volume
73
Issue
2-3
Year of publication
1999
Pages
91 - 101
Database
ISI
SICI code
0168-1656(19990820)73:2-3<91:VFFROW>2.0.ZU;2-Q
Abstract
The application of fertility control technologies for the management of ani mal populations is still a relatively new concept and remains to be proven on a large scale. While there have been demonstrations of its utility using crude antigenic preparations of porcine zona pellucida, refined, cheap and easily delivered vaccines are still in the early phases of development, es pecially those required for remote delivery to free-ranging wild animal pop ulations. The relative slow emergence of such technologies for practical ap plication clearly reflects the complexity of the science and the requiremen t for a multidisciplinary research approach when attempting to develop such technologies for wild animal management. In many cases, one of the areas w here further information is required is the immunobiology of such target sp ecies. Effective immunocontraceptive vaccines will also be critically depen dent upon the design of the delivery systems. These will be unique to each species under study. A major challenge for free-ranging species will be to ensure that the vaccine can induce a long-lasting immune response to a high percentage of the target population, thus reducing the frequency and, henc e, the cost of vaccine application. Many of the delivery systems being cons idered will utilise recombinant organisms. Hence, considerations on the use of such organisms needs to take into account the political, ethical and sa fety constraints prior to any environmental release. Also of prime importan ce is the issue of species specificity. In some instances, this will be a m ajor challenge and careful thought will need to be given to ensure that spe cificity can be built into the vaccine at several levels. These might inclu de the target antigen or epitopes, the microbial or other delivery vector, and, where applicable, the bait matrix and any target-specific attractive p roperties it may require. If these caveats can be satisfied and the public is able to accept the use of such vaccines, the potential for their applica tion to manage animal populations and their impact is most certainly assure d. (C) 1999 Elsevier Science B.V. All rights reserved.